Vimarsana
Biggest News Aggregation in the World

Page 2 - Iodine Software News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iodine Software. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iodine Software Today - Breaking & Trending Today

Iodine Software Expands Partnership With OpenAI, Adds GPT-4 to Its Products - Vimarsana News

Iodine Software Expands Partnership With OpenAI, Adds GPT-4 to Its Products

Iodine Software recently announced that it is expanding its relationship with OpenAI. By doing so, Iodine will integrate the latest GPT-4 language model into its existing AI technologies and datasets, specifically its AwareCDI product suite.

Iodine Software expands partnership with OpenAI - Vimarsana News

Iodine Software expands partnership with OpenAI

The company says it will infuse generative AI and large language models across the breadth of its AwareCDI product suite to streamline physician administrative burdens and to help hospitals and health systems capture more earned revenue.

Iodine Software, OpenAI Partner to Resolve Revenue Leakage - Vimarsana News

Iodine Software, OpenAI Partner to Resolve Revenue Leakage

Iodine Software, a pioneer in healthcare AI technology, today announced an expanded relationship withOpenAI, an AI research an…

JETNET to Showcase Training Courses and Cutting-Edge Research Products at EBACE 2023 - Vimarsana News

JETNET to Showcase Training Courses and Cutting-Edge Research Products at EBACE 2023

Utica, New York (PRWEB) May 18, 2023 -- JETNETwill display their innovative training courses and their research products at the European Business Aviation

Source: prweb.com
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion - Vimarsana News

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a ...